EicOsis Human Health, Inc. — Pain Research

Grant Investigators: Chris Somerville and Heather Youngs

This page was reviewed but not written by the grant investigators. EicOsis staff also reviewed this page prior to publication.

The Open Philanthropy Project recommended an investment of $5,000,000 in EicOsis to support clinical trials on a novel, non-opioid, oral therapy for neuropathic and inflammatory pain. Chronic pain affects as many as 100 million people in the U.S. alone, and total costs for treating pain have been estimated to be as high as $635 billion annually.Source: Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research We believe alternate therapies for chronic pain could help address the epidemic of opioid abuse and addiction. EicOsis previously received Blueprint funding for neuroscience research from the National Institutes of Health. This seed-stage investment is intended to support continued early research and development in the hopes that EicOsis can subsequently raise additional funds from other investors.

This falls within our work on scientific research, and specifically within our interest in advancing human health and wellbeing.